Moleculin Biotech Stock Forward View - Simple Exponential Smoothing
| MBRX Stock | USD 2.06 -0.02 -0.96% |
The Simple Exponential Smoothing reference data for Moleculin Biotech is derived from the equity's published trading history. The resulting forecast and deviation statistics are presented as reference data for informational context. Forecast values and accuracy statistics are presented for informational purposes. All values shown are derived from publicly available market data.
The Simple Exponential Smoothing forecasted value of Moleculin Biotech on the next trading day is expected to be 2.06 with a mean absolute deviation of 0.16 and the sum of the absolute errors of 9.43.This simple exponential smoothing model begins by setting Moleculin Biotech forecast for the second period equal to the observation of the first period. In other words, recent Moleculin Biotech observations are given relatively more weight in forecasting than the older observations. The forecast reference data presented here for Moleculin Biotech reflects Simple Exponential Smoothing model output and is intended as reference material for analytical use. Simple Exponential Smoothing Price Forecast For the 23rd of March
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Moleculin Biotech on the next trading day is expected to be 2.06 with a mean absolute deviation of 0.16 , mean absolute percentage error of 0.10 , and the sum of the absolute errors of 9.43 .Please note that although there have been many attempts to predict Moleculin Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Moleculin Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Moleculin Biotech | Moleculin Biotech Price Prediction | Research Analysis |
Forecasted Value
The next-day forecast for Moleculin Biotech focuses on identifying predictive downside and upside bands that can frame a realistic trading range. Used properly, these levels provide context around forecast dispersion rather than certainty about the next closing print.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Moleculin Biotech stock data series using in forecasting. Note that when a statistical model is used to represent Moleculin Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.997 |
| Bias | Arithmetic mean of the errors | 0.0348 |
| MAD | Mean absolute deviation | 0.1572 |
| MAPE | Mean absolute percentage error | 0.0483 |
| SAE | Sum of the absolute errors | 9.43 |
Other Forecasting Options for Moleculin Biotech
Fibonacci retracement levels applied to Moleculin Stock price swings identify potential support and resistance zones. Extreme price moves in Moleculin occur more frequently than standard risk models assume. Support and resistance levels derived from Moleculin Biotech's historical data identify zones where buying or selling pressure has stalled moves. A volume spike without a corresponding price move can signal accumulation or distribution ahead of a directional breakout.Moleculin Biotech Related Equities
Investors studying Moleculin Biotech often look at related stocks within the Health Care space to gauge pricing and results. Looking at Moleculin Biotech's pricing multiples next to these peers shows if the stock trades at a premium or discount. Peer review is most useful when paired with absolute pricing and trend checks. The data below allows side-by-side review across the most common financial metrics.
| Risk & Return | Correlation |
Moleculin Biotech Market Strength Events
Tracking market strength indicators for Moleculin Biotech provides context for understanding stock momentum dynamics. Tracking these indicators helps identify periods where trading Moleculin Biotech is likely to be most rewarding. These tools are essential for timing trades in Moleculin Biotech with a quantitative framework. Market strength indicators for Moleculin Biotech are most useful when viewed as part of a broader analytical framework.
Moleculin Biotech Risk Indicators
Properly assessing Moleculin Biotech's risk indicators is a prerequisite for building reliable price forecasts. This analysis provides context for determining the appropriate level of risk to accept when holding Moleculin Biotech's. Analyzing Moleculin Biotech's risk indicators provides a critical input for investment risk management. By quantifying the risk in Moleculin Biotech's investment, investors can make more informed decisions about hedging strategies.
| Mean Deviation | 4.23 | |||
| Standard Deviation | 7.23 | |||
| Variance | 52.28 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Moleculin Biotech
Story coverage around Moleculin Biotech often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Contributor Headline
Latest Perspective From Macroaxis
Moleculin Biotech Short Properties
Reviewing short-oriented indicators for Moleculin Biotech is useful because long and short participants often create very different signals for timing and volatility. The stronger read compares short sentiment with trend behavior, volume, and the broader market narrative.
| Common Stock Shares Outstanding | 11.8 M | |
| Cash And Short Term Investments | 8.9 M |